Newron Pharmaceuticals SpA (NP5) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	5.95M	5.95M	3.61M	3.61M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	3.04M	3.04M	4.52M	4.52M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.24M	2.24M	2.12M	2.12M
Operating expense	5.28M	5.28M	6.64M	6.64M
Total operating expenses	5.28M	5.28M	6.64M	6.64M
Operating income	672.50K	672.50K	-3.02M	-3.02M
Other non operating income	285.50K	285.50K	-2.14M	-2.14M
EBT including unusual items	-28.50K	-28.50K	-6.15M	-6.15M
EBT excluding unusual items	-28.50K	-28.50K	-6.15M	-6.15M
Income tax expense	8.00K	8.00K	434.50K	434.50K
Effective tax rate	-28.07%	-28.07%	-7.07%	-7.07%
Other operating expenses	-	-	-	-
Net income	-36.50K	-36.50K	-6.58M	-6.58M
Net profit margin	-0.61%	-0.61%	-182.15%	-182.15%
Earnings per share	-	-	-	-
Interest and investment income	149.00K	149.00K	120.50K	120.50K
Interest expense	-1.11M	-1.11M	-1.09M	-1.09M
Net interest expenses	-963.50K	-963.50K	-966.00K	-966.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	715.00K	715.00K	-3.00M	-3.02M
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance